.
MergerLinks Header Logo

New Deal


Announced

Addition led a $110m Series D round in Lyra Health.

Financials

Edit Data
Transaction Value£83m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

healthcare solutions

healthcare information services

Acquisition

Completed

Private Equity

Minority

Friendly

United States

healthcare software platform

information services

Private

Single Bidder

Health Care Services

Venture Capital

Synopsis

Edit

Addition, an investment firm. led a $110m Series D round in Lyra Health, a mental healthcare services provider. The round was joined by joined by Adams Street Partners and existing investors, including Howard Schultz, Casdin Capital, Glynn Capital, Greylock Partners, IVP, Meritech Capital Partners, Providence Ventures and Tenaya Capital. “Whether you’re dealing with a preexisting mental health condition that has intensified or new symptoms that have arisen during the pandemic, these are challenging times for many people. We are proud to support employers that are prioritizing mental health and will use this new funding to help even more organizations support the mental health and well-being of their most important asset—their people,” said David Ebersman, Lyra Health Co-Founder and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US